Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Common Equity (2021 - 2025)

Historic Common Equity for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to $5.6 million.

  • Tivic Health Systems' Common Equity rose 9728.3% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 9728.3%. This contributed to the annual value of $2.5 million for FY2024, which is 2918.99% down from last year.
  • According to the latest figures from Q3 2025, Tivic Health Systems' Common Equity is $5.6 million, which was up 9728.3% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Tivic Health Systems' Common Equity ranged from a high of $13.3 million in Q4 2021 and a low of -$2.5 million during Q1 2021
  • Over the past 5 years, Tivic Health Systems' median Common Equity value was $3.7 million (recorded in 2025), while the average stood at $4.8 million.
  • Within the past 5 years, the most significant YoY rise in Tivic Health Systems' Common Equity was 54072.31% (2022), while the steepest drop was 7264.92% (2022).
  • Quarter analysis of 5 years shows Tivic Health Systems' Common Equity stood at $13.3 million in 2021, then tumbled by 72.65% to $3.6 million in 2022, then fell by 1.38% to $3.6 million in 2023, then decreased by 29.19% to $2.5 million in 2024, then surged by 120.55% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $3.7 million for Q2 2025, and $3.0 million during Q1 2025.